The effect of aminocandin (HMR 3270) on the in-vitro adherence of Candida albicans to polystyrene surfaces coated with extracellular matrix proteins or fibronectin

Clinical Microbiology and Infection

Volumn 13, Issue 3, 2007, Pages 311-315

  Cateau, E ^a   Levasseur, P ^b   Borgonovi, M ^b   Imbert, Christine ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b Novexel SA   (France)

Author keywords

Adhesion; Aminocandin; Biofilm; Candida albicans; Echinocandins; Inhibition

Indexed keywords

AMINOCANDIN; ECHINOCANDIN; FIBRONECTIN; FLUCONAZOLE; HMR 3270; POLYSTYRENE; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDEMIA; CULTURE MEDIUM; DILUTION; DRUG EFFECT; DRUG SENSITIVITY; FUNGAL STRAIN; FUNGUS GROWTH; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

CANDIDA ALBICANS;

EID: 34247275327     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01644.x     Document Type: Article

References (21)

1. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11: 30-36.
2. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255-267.
3. Mukherjee PK, Zhou G, Munyon R, Ghannoum MA. Candida biofilm: A well-designed protected environment. Med Mycol 2005; 43: 191-208.
4. Gristina A. Biomaterial centered infection: Microbial adhesion versus tissue integration. Science 1987; 237: 1588-1595.
5. Chaffin WL, Lopez-Ribot JL, Casanova M et al. Cell wall and secreted proteins of Candida albicans: Identification, function, and, expression. Microbiol Mol Biol Rev 1998; 62: 130-180.
6. Mah TFC, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34-39.
7. Donlan RM, Costerton JW. Biofilms: Survival mechanisms on clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-193.
8. Kalya AV, Ahearn DG. Increased resistance to antibiotics of Candida spp. adhered to silicone. J Ind Microbiol 1995; 14: 451-455.
9. Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intra-vascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-1272.
10. Douglas CM, D'Ippolito JA, Shei GJ et al. Identification of the FKS 1 gene of Candida albicans as the essential target of 1,3-β-D-glucan synthase inhibitors. Antimicrob Agents Chemother 1997; 41: 2471-2479.
11. Letscher-Bru V, Herbrecht R. Caspofungin: The first representative of a new antifungal class. J Antimicrob Chemother 2003; 51: 513-521.
12. Soustre J, Rodier MH, Imbert-Bouyer S et al. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins. J Antimicrob Chemother 2004; 53: 522-525.
13. Andes D, Marchillo K, Lowther J et al. In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model. Antimicrob Agents Chemother 2003; 47: 1187-1192.
14. Imbert C, Imbert S, Rodier MH et al. Influence of sub-inhibitory concentrations of systemic antifungal agents on adherence, filamentation and mitochondrial metabolism of Candida albicans. J Med Mycol 2001; 11: 14-18.
15. Imbert C, Rodier MH, Daniault G et al. Influence of sub-inhibitory concentrations of conventional antifungals on metabolism of Candida albicans and on its adherence to polystyrene and extracellular matrix proteins. Med Mycol 2002; 40: 123-129.
16. Yan S, Rodrigues RG, Cahn-Hidalgo D et al. Hemoglobin induces binding of several extracellular matrix proteins to Candida albicans. Identification of a common receptor for fibronectin, fibrinogen, and laminin. J Biol Chem 1998; 273: 5638-5644.
17. Nguyen MH, Yu CY. Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole. J Clin Microbiol 1999; 37: 141-145.
18. Bachmann SP, Van de Walle K, Ramage G et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002; 46: 3591-3596.
19. Bachmann SP, Ramage G, Van de Walle K et al. Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother 2003; 47: 3657-3659.
20. Chandra J, Mukherjee PK, Leidich SD et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 2001; 80: 903-908.
21. Kuhn DM, George T, Chandra J et al. Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773-1780.